Neurology and Neurosurgery

1-7 of 7

• 

  RestartResume

  Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation 

  Medical Industry Feature

  Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation 

  • 

    

    Marwan Sabbagh, MD, FAAN, CCR

    Peer

  • 

    

    Cara Leahy, DO

    Peer

  • 

    

    David Weisman, MD

    Peer

• 

  RestartResume

  Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice

  Medical Industry Feature

  Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    George Grossberg, MD

    Peer

  • 

    

    Angela Sanford, MD, CMD

    Peer

• 

  RestartResume

  Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers

  Medical Industry Feature

  Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers

  • 

    

    Yuval Zabar, MD

    Peer

  • 

    

    Michelle Mielke, PhD

    Peer

  • 

    

    Henrik Zetterberg, MD, PhD

    Peer

• 

  RestartResume

  Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA

  Medical Industry Feature

  Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA

• 

  RestartResume

  Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression

  Medical Industry Feature

  Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression

  • 

    

    Holly M. Brothers, PhD

    Peer

  • 

    

    Niklas Mattsson-Carlgren, MD, PhD

    Peer

• 

  RestartResume

  New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma

  Medical Industry Feature

  New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma

  • 

    

    Brian Gill, M.D.

    Peer
• advertisement

• 

  RestartResume

  Reassessing the Full Clinical Picture of ADHD

  Medical Industry Feature

  Reassessing the Full Clinical Picture of ADHD

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Ann Childress, MD

    Peer